Literature DB >> 21239176

APOBEC3G: a double agent in defense.

Harold C Smith1.   

Abstract

APOBEC3G (A3G) is an effective cellular host defense factor under experimental conditions in which a functional form of the HIV-encoded protein Vif cannot be expressed. Wild-type Vif targets A3G for proteasomal degradation and when this happens, any host defense advantage A3G might provide is severely diminished or lost. Recent evidence cast doubt on the potency of A3G in host defense and suggested that it could, under some circumstances, promote the emergence of more virulent HIV strains. In this article, I suggest that it is time to recognize that A3G has the potential to act as a double agent. Future research should focus on understanding how cellular and viral regulatory mechanisms enable the antiviral function of A3G, and on the development of novel research reagents to explore these pathways.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21239176      PMCID: PMC3086942          DOI: 10.1016/j.tibs.2010.12.003

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  78 in total

1.  Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.

Authors:  Xianghui Yu; Yunkai Yu; Bindong Liu; Kun Luo; Wei Kong; Panyong Mao; Xiao-Fang Yu
Journal:  Science       Date:  2003-10-16       Impact factor: 47.728

2.  Population level analysis of human immunodeficiency virus type 1 hypermutation and its relationship with APOBEC3G and vif genetic variation.

Authors:  Craig Pace; Jean Keller; David Nolan; Ian James; Silvana Gaudieri; Corey Moore; Simon Mallal
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

3.  Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation.

Authors:  Andrew Mehle; Joao Goncalves; Mariana Santa-Marta; Mark McPike; Dana Gabuzda
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

4.  APOBEC3G DNA deaminase acts processively 3' --> 5' on single-stranded DNA.

Authors:  Linda Chelico; Phuong Pham; Peter Calabrese; Myron F Goodman
Journal:  Nat Struct Mol Biol       Date:  2006-04-23       Impact factor: 15.369

5.  Mutational alteration of human immunodeficiency virus type 1 Vif allows for functional interaction with nonhuman primate APOBEC3G.

Authors:  Bärbel Schröfelbauer; Tilo Senger; Gerard Manning; Nathaniel R Landau
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

6.  The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes.

Authors:  J H Simon; M H Malim
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

7.  The HIV-1 central polypurine tract functions as a second line of defense against APOBEC3G/F.

Authors:  Chunling Hu; Dyana T Saenz; Hind J Fadel; William Walker; Mary Peretz; Eric M Poeschla
Journal:  J Virol       Date:  2010-09-15       Impact factor: 5.103

8.  A patch of positively charged amino acids surrounding the human immunodeficiency virus type 1 Vif SLVx4Yx9Y motif influences its interaction with APOBEC3G.

Authors:  Gongying Chen; Zhiwen He; Tao Wang; Rongzhen Xu; Xiao-Fang Yu
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

9.  RNA-dependent oligomerization of APOBEC3G is required for restriction of HIV-1.

Authors:  Hendrik Huthoff; Flavia Autore; Sarah Gallois-Montbrun; Franca Fraternali; Michael H Malim
Journal:  PLoS Pathog       Date:  2009-03-06       Impact factor: 6.823

10.  Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G.

Authors:  Sara L Sawyer; Michael Emerman; Harmit S Malik
Journal:  PLoS Biol       Date:  2004-07-20       Impact factor: 8.029

View more
  25 in total

Review 1.  Functions and regulation of the APOBEC family of proteins.

Authors:  Harold C Smith; Ryan P Bennett; Ayse Kizilyer; William M McDougall; Kimberly M Prohaska
Journal:  Semin Cell Dev Biol       Date:  2011-10-06       Impact factor: 7.727

2.  Deaminase activity on single-stranded DNA (ssDNA) occurs in vitro when APOBEC3G cytidine deaminase forms homotetramers and higher-order complexes.

Authors:  William M McDougall; Chinelo Okany; Harold C Smith
Journal:  J Biol Chem       Date:  2011-07-07       Impact factor: 5.157

3.  Structural and functional assessment of APOBEC3G macromolecular complexes.

Authors:  Bogdan Polevoda; William M McDougall; Ryan P Bennett; Jason D Salter; Harold C Smith
Journal:  Methods       Date:  2016-03-14       Impact factor: 3.608

4.  RNA binding to APOBEC3G induces the disassembly of functional deaminase complexes by displacing single-stranded DNA substrates.

Authors:  Bogdan Polevoda; William M McDougall; Bradley N Tun; Michael Cheung; Jason D Salter; Alan E Friedman; Harold C Smith
Journal:  Nucleic Acids Res       Date:  2015-09-30       Impact factor: 16.971

5.  Direct evidence that RNA inhibits APOBEC3G ssDNA cytidine deaminase activity.

Authors:  William M McDougall; Harold C Smith
Journal:  Biochem Biophys Res Commun       Date:  2011-08-11       Impact factor: 3.575

6.  Synthesis and structure-activity relationship studies of HIV-1 virion infectivity factor (Vif) inhibitors that block viral replication.

Authors:  Akbar Ali; Jinhua Wang; Robin S Nathans; Hong Cao; Natalia Sharova; Mario Stevenson; Tariq M Rana
Journal:  ChemMedChem       Date:  2012-05-03       Impact factor: 3.466

7.  DNA mutagenic activity and capacity for HIV-1 restriction of the cytidine deaminase APOBEC3G depend on whether DNA or RNA binds to tyrosine 315.

Authors:  Bogdan Polevoda; Rebecca Joseph; Alan E Friedman; Ryan P Bennett; Rebecca Greiner; Thareendra De Zoysa; Ryan A Stewart; Harold C Smith
Journal:  J Biol Chem       Date:  2017-04-05       Impact factor: 5.157

8.  GANP interacts with APOBEC3G and facilitates its encapsidation into the virions to reduce HIV-1 infectivity.

Authors:  Kazuhiko Maeda; Sarah Ameen Almofty; Shailendra Kumar Singh; Mohammed Mansour Abbas Eid; Mayuko Shimoda; Terumasa Ikeda; Atsushi Koito; Phuong Pham; Myron F Goodman; Nobuo Sakaguchi
Journal:  J Immunol       Date:  2013-11-06       Impact factor: 5.422

Review 9.  The APOBEC Protein Family: United by Structure, Divergent in Function.

Authors:  Jason D Salter; Ryan P Bennett; Harold C Smith
Journal:  Trends Biochem Sci       Date:  2016-06-06       Impact factor: 13.807

Review 10.  The multifaceted roles of RNA binding in APOBEC cytidine deaminase functions.

Authors:  Kimberly M Prohaska; Ryan P Bennett; Jason D Salter; Harold C Smith
Journal:  Wiley Interdiscip Rev RNA       Date:  2014-03-24       Impact factor: 9.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.